Similar to Plasmodium vivax, Plasmodium ovale causes a milder form of malaria that can remain dormant in the liver and cause relapses months or even years after the initial infection. Although it’s less common globally, it is still prevalent in parts of Africa and Southeast Asia. The infection cycle with P. ovale involves red blood cells, and symptoms mirror other malaria-causing species, including intermittent fevers, fatigue, and muscle pain. Due to its ability to stay dormant, it poses a significant risk of long-term health issues if not properly treated.
Eliminating Plasmodium ovale from the body requires a dual approach: treating both the active bloodstream parasites and the dormant liver stages. This comprehensive treatment ensures a complete cure and prevents future relapses, leading to better overall health. Implementing preventive strategies like improved sanitation, mosquito control, and education about the use of prophylactic medications can further help in reducing the spread of P. ovale and improving community health outcomes.
